We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Vitamin Metabolism in Kidney Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00257439
Recruitment Status : Unknown
Verified September 2012 by Henrik Birn, Aalborg Hospital.
Recruitment status was:  Recruiting
First Posted : November 23, 2005
Last Update Posted : September 25, 2012
Sponsor:
Collaborators:
University of Aarhus
Aarhus University Hospital
Information provided by (Responsible Party):
Henrik Birn, Aalborg Hospital

Brief Summary:
The purpose of this study is to evaluate the urinary excretion and renal metabolism of vitamins, in particular vitamin B12 and folate, in relation to various renal conditions involving loss of renal function and/or proteinuria.

Condition or disease
Kidney Failure

Study Type : Observational
Estimated Enrollment : 100 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Vitamin Metabolism in Kidney Disease
Study Start Date : December 2005

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Kidney Diseases
U.S. FDA Resources

Group/Cohort
CKD
Elevated se-creatinine + proteinuria
Healthy controls
Healthy controls, normal se-creatinine, no proteinuria




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
  1. CKD, proteinuria
  2. Healthy controls
Criteria

Inclusion Criteria:

  • Admission to the Department of Nephrology, Aalborg Hospital
  • Elevated serum creatinine
  • Proteinuria
  • Informed and written consent

Control subjects:

  • Normal serum creatinine and creatinine clearance
  • No proteinuria

Exclusion Criteria:

  • Vitamin supplementation (exceeding predefined values)
  • Renal replacement therapy (dialysis)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00257439


Contacts
Contact: Lars Mølby, MD 9932 1111 ext 2241 moelby@dadlnet.dk

Locations
Denmark
Department of Nephrology, Aalborg Hospital Recruiting
Aalborg, Denmark, DK-9000
Contact: Jakob Sølling, MD, PhD    +45 9932 1111 ext 2237    aas.u19116@nja.dk   
Principal Investigator: Henrik Birn, MD, PhD         
Sponsors and Collaborators
Aalborg Universitetshospital
University of Aarhus
Aarhus University Hospital
Investigators
Principal Investigator: Henrik Birn, MD, PhD Department of Nephrology, Aalborg Hospital

Responsible Party: Henrik Birn, MD, Aalborg Hospital
ClinicalTrials.gov Identifier: NCT00257439     History of Changes
Other Study ID Numbers: VN 2005/44
First Posted: November 23, 2005    Key Record Dates
Last Update Posted: September 25, 2012
Last Verified: September 2012

Keywords provided by Henrik Birn, Aalborg Hospital:
Vitamin B12
Folic Acid

Additional relevant MeSH terms:
Kidney Diseases
Renal Insufficiency
Urologic Diseases
Vitamins
Micronutrients
Growth Substances
Physiological Effects of Drugs